News & Views

  • Professor Karim Labib

Duplication Process Suggests Alternative Approach to Cancer

Jun 19 2017 Comments 0

Scientists at Dundee studying the processes behind cell duplication have made a discovery that they hope may help to tackle cancer one day. Professor Karim Labib and colleagues in the School of Life Sciences at Dundee had previously studied how proteins in simple yeast cells combine to build the replisome, a molecular ‘machine’ which plays a vital role in copying the double helix of DNA that is at the heart of each chromosome. The replisome is only built once during the life of each cell; it is then disassembled to ensure that cells just make one single copy of each chromosome.

They have found the process to be more complicated in animals, which have at least two different disassembly mechanisms and importantly, that the gene needed for one of these processes is lost in a number of human cancers.

“Ever since Watson and Crick first described the structure of DNA we have known that cells copy chromosomes, but we are still learning how it works,” said Professor Labib. “By looking at yeast, which is very similar genetically to humans, we discovered that one of the many components of the replisome undergoes a change called ‘ubiquitylation’, after the chromosomes have been copied, which marks the replisome for disassembly by the cell’s recycling machinery. This is a good thing, as genetic studies show that if the replisome is not taken apart but instead remains glued to the chromosomes, then this can lead to major problems.

“What we have now discovered is that the machinery that marks the yeast replisome for destruction doesn’t exist in animals, so there had to be something else driving this process. By studying a small worm called Caenorhabditis elegans we found that animals actually have two different mechanisms for replisome dissassembly. If one pathway fails to do its job then the second kicks in as a back-up.

“What makes this particularly interesting is that a gene required for the second mechanism is known to be mutated in a variety of human cancers, including some lymphomas, glioblastomas and myelomas. Our work with this gene in worms suggests a new way to treat the corresponding cancers in humans,” Professor Labib added.

The paper is published in the latest edition of the journal Nature Cell Biology.

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

International Labmate Buyers Guide 2017

June 2017

A Comprehensive Bibliography of Who’s Who in the Laboratory and Analytical Science Industry This directory has been produced as a reference of manufacturers and suppliers in the Laboratory an...

View all digital editions

Events

MARELEC 2017

Jun 27 2017 Liverpool, UK

INTERPHEX JAPAN 2017

Jun 28 2017 Tokyo, Japan

MMC 2017

Jul 03 2017 Manchester Central, Manchester, UK

HPLC Method Development

Jul 04 2017 London, UK

View all events